Clinical Trial Update: Open Label Phase IIa Trial Evaluating the Effect and Safety of Transplantation of Fecal Microbiota in Children With Autism Spectrum Disorders and Gastrointestinal Symptoms [Phase 2]

View source ↗

Summary

Open-label Phase IIa trial evaluating the effect and safety of fecal microbiota transplantation in children with autism spectrum disorder and gastrointestinal s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autism Spectrum Disorder

Drugs mentioned

• Fecal microbiota transplantation (fecal microbiota transplantation)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Autism Spectrum Disorder, Fecal Microbiota Transplantation (FMT) | Phase 2 | Status: NOT_YET_RECRUITING